Which has the lower trailing P/E, GEHC or WST?

GEHC has the lower trailing P/E: GEHC trades at 19.31 and WST at 47.35. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, GEHC or WST?

Over the past five years, WST grew revenue faster — GEHC at a 3.74% CAGR versus WST at 5.68%.

Does GEHC or WST pay a bigger dividend?

GEHC yields 0.22% and WST yields 0.26% based on trailing dividends and the latest price.

Is GEHC or WST more profitable?

WST runs the higher net margin — GEHC at 7.86% versus WST at 16.98%.

GE HealthCare Technologies Inc. (GEHC) vs West Pharmaceutical Services, Inc. (WST)

A side-by-side comparison of GE HealthCare Technologies Inc. and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

GEHC

GE HealthCare Technologies Inc.

$30.10B

$66.63HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

WST

West Pharmaceutical Services, Inc.

$26.06B

$370.29HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

Total return — GEHC vs WST

growth of $100 · dividends reinvested · last 4y

GEHC +9.3% (+2.2%/yr)WST +44.2% (+9.6%/yr)WST compounded faster over this window

GEHC WST

GEHC vs WST: by the numbers

•GEHC is the larger company ($30.10B vs $26.06B market cap).
•GEHC trades at the lower trailing earnings multiple (19.31 vs 47.35 P/E), one valuation lens rather than an overall verdict.
•WST converts more revenue to profit (16.98% vs 7.86% net margin).
•WST grew revenue faster over the past five years (5.68% vs 3.74% CAGR).
•WST pays the higher dividend yield (0.26% vs 0.22%).

Metrics side by side

Valuation

Metric	GEHC	WST
P/E ratio	19.31	47.35
Forward P/E	13.53	41.30
P/S ratio	1.49	7.83
P/B ratio	2.74	8.71
EV / EBITDA	10.64	29.92
FCF yield	2.97%	1.68%

Profitability

Metric	GEHC	WST
Gross margin	42.90%	36.77%
Operating margin	12.70%	20.64%
Net margin	7.86%	16.98%
ROE	14.51%	18.89%
ROIC	6.94%	15.77%

Dividends

Metric	GEHC	WST
Dividend yield	0.22%	0.26%
Payout ratio	4.06%	11.25%

Growth (annualized)

Metric	GEHC	WST
Revenue CAGR (5Y)	3.74%	5.68%
EPS CAGR (5Y)	0.67%	7.85%
FCF CAGR (5Y)	1.07%	8.74%
Total return CAGR (5Y)	N/A	-5.84%

Frequently asked

Which has the lower trailing P/E, GEHC or WST?: GEHC has the lower trailing P/E: GEHC trades at 19.31 and WST at 47.35. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, GEHC or WST?: Over the past five years, WST grew revenue faster — GEHC at a 3.74% CAGR versus WST at 5.68%.
Does GEHC or WST pay a bigger dividend?: GEHC yields 0.22% and WST yields 0.26% based on trailing dividends and the latest price.
Is GEHC or WST more profitable?: WST runs the higher net margin — GEHC at 7.86% versus WST at 16.98%.

Go deeper

Full GEHC analysis Full WST analysis Interactive comparison tool

Dig into the metrics

GE HealthCare Technologies P/E ratio West Pharmaceutical Services P/E ratio GE HealthCare Technologies dividend yield West Pharmaceutical Services dividend yield GE HealthCare Technologies ROE West Pharmaceutical Services ROE GE HealthCare Technologies operating margin West Pharmaceutical Services operating margin GE HealthCare Technologies revenue growth West Pharmaceutical Services revenue growth GE HealthCare Technologies free cash flow West Pharmaceutical Services free cash flow

GE HealthCare Technologies & West Pharmaceutical Services appear in these rankings

25+ Year Dividend Growers Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.